PharmaFutures was set up in response to the serious challenges facing the pharmaceutical industry and, in particular, the dilemma of meeting short-term profitability for investors while meeting growing societal expectations of effective, affordable and accessible medicines. The aim of this project is to help investors and companies reconcile these competitive tensions to enable the industry to more systematically and strategically address these unmet societal needs.


The industry’s social contract is under severe strain. There is an urgent need for new treatments for antibiotics and diseases like Alzheimer’s. It is in the interest of patients, healthcare providers, industry and pension holders to work together to create the best model for bringing new drugs to market.

Sophia Tickell, Director, PharmaFutures